Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between JRNYS and WellMedr for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
JRNYS offers both semaglutide and tirzepatide at $89/month with a rating of 7.9/10. WellMedr also provides both semaglutide and tirzepatide at $199/month with a 7.5/10 rating.
The price difference of $110/month is significant - JRNYS is the more budget-friendly option, while WellMedr positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | JRNYS | WellMedr |
|---|---|---|
| Monthly Price | $89 | $199 |
| Rating | 7.9/10 | 7.5/10 |
| Medications | semaglutide, tirzepatide | semaglutide, tirzepatide |
| Insurance Accepted | Yes | No |
| Support Hours | 24/7 support claimed | 7 days a week (specific hours not published) |
| Live Chat | No | Available |
| Free Shipping | Yes | Yes |
| Shipping Speed | Medications delivered to your door; timeframe not published | Not published (refills ship every 4 weeks) |
| Mobile App | No | No |
| Dedicated Coach | Included | Included |
| Follow-up Frequency | Daily monitoring and coaching included in the membership | Care coaching every 2 weeks, unlimited messaging in between |
| Money-back Guarantee | None published; a cancellation policy is provided | Advertised as 100% back if you don't lose weight in 90 days, but the published refund policy contradicts this |
| Cancellation Policy | Published as a separate policy document | Cancel anytime, but policy requires 48-72 hours notice and allows no refund once an intake is approved |

